Lithium Monitoring — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Plasma lithium concentration, weight or BMI, urea and electrolytes including calcium, eGFR, and thyroid function
The correct answer is A. NICE recommends measuring plasma lithium every 6 months after the first year in low-risk patients. Monitoring should remain every 3 months in specified higher-risk groups, including older people, those taking interacting medicines, those with poor adherence or symptom control, and those whose last lithium concentration was at least 0.8 mmol/L. Weight or BMI, urea and electrolytes including calcium, eGFR and thyroid function are required every 6 months for everyone established on lithium. Option D omits essential toxicity monitoring. Option C resembles the broader annual physical health assessment for bipolar disorder but does not replace lithium-specific monitoring. Prolactin testing is principally relevant to prolactin-raising antipsychotics and is not routine lithium monitoring. An ECG is indicated when initiating lithium in someone with cardiovascular disease or risk factors, not routinely at each review.
Reference: National Institute for Health and Care Excellence. Bipolar disorder: assessment and management (CG185), sections 1.10.19–1.10.21. Published 2014; updated 2 September 2025. https://www.nice.org.uk/guidance/cg185/chapter/recommendations